Thanks to SoCalBio Weekly Update Sponsor |
Featured SoCalBio Service Provider
West Coast Clinical Trials (Cypress) 
| | Led by Dr. Kenneth Kim (above), West Coast Clinical Trials (WCCT) is a privately owned independent Phase I-IV CRO. WCCT has a unique focus on ethno-bridging studies including Japanese bridging/population trials. In addition, the firm has extensive experience with healthy volunteer studies including First-in-Human (FIH) as well as specific therapeutic expertise in Allergy, Asthma, Infectious Disease, Pediatric, Renal, Serial ECGs, and Vaccines... Learn more | | Join SoCalBio |
Recommended Events
 September 26- 28
Washington DC
|
Join SoCalBio
 Join SoCalBio leaders to promote the biotech and device industries in the Greater Los Angeles Metro Area for job creation and overall economic growth.
When you join, you will enjoy significant discounts on products and services from lab and office supplies to insurance and scientific publications. Discounts are exclusive to SoCalBio member companies in Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino counties... Click here to see why |  |
| Thanks to SoCalBio Media Partners |
|
|  |  |
New SoCalBio Member
| Dergosits & Noah
(San Francisco and Los Angeles) | | The law firm of Dergosits & Noah LLP assists clients nationally and internationally, offering the full spectrum of intellectual property services, focusing on San Francisco IP law, patent preparation and prosecution, trademark transactions, patent transactions. For more info, contact Mananli Dighe at 310-663-5100 |
Med device Competitiveness
| | Is the U.S. Losing its Medical Device Innovation Mojo? PwC Report Says Yes |  While the U.S. is still the undisputed leader, the foundation for much of its med-tech strength is weakening, according to PwC. The firm's report, written by a team led by former med device entrepreneur Chris Wasden, sought to put together a five-point list of essential ingredients for med-tech innovation, and then grade the U.S. on it against other countries over the past five years. The idea was that med device entrepreneurs and investors needed to stop passing along anecdotal stories, and start coming up with some convincing data to support their arguments, if they want to really persuade lawmakers, insurers, and citizens to provide more support for med-tech innovation ..... Click here to access report |
Med device Investing
| | Med Device VC Investing Falls 9% in 2010 | | Venture capital investment in the medical device industry fell nine percent in 2010, ending the year as the fourth largest investment sector with $2.3 billion going into 324 deals. That's slightly more deals than in 2009, when medical devices ranked third among all industries. The figures were released in a MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters... Read more |
New Drug Development
| | Federal Research Center Will Help Develop Medicines |  The Obama administration has become so concerned about the slowing pace of new drugs coming out of the pharmaceutical industry that officials have decided to start a billion-dollar government drug development center -- to be called the National Center for Advancing Translational Sciences -- to help create medicines... Read more |
Under the Spotlight
| | Beckman Coulter on Track for Getting Test Back After Recall |  Brea-based Beckman Coulter Inc. is on schedule to have a profitable heart test back on the market by midyear, according to a regulatory filing by the maker of medical diagnostic products. Beckman said in a Securities and Exchange Commission filing last week that it expects to submit a reworked troponin test to the Food and Drug Administration in May or June. The projection comes amid a clinical trial Beckman is conducting, the company said. "We take a fairly confident view with the progress that we've made in the trial to this point," Paul Glyer (photo right), Beckman's senior vice president of strategy, business development and communications, said at a recent investor conference... Read more |
Inhaled Insulin
| Execs Say Inhaled Insulin Maker Still Breathing:
MannKind's future may hinge on deep pockets of owner Alfred E. Mann |  Last week's news that the Food and Drug Administration wouldn't approve MannKind Inc.'s experimental insulin inhaler without additional clinical trials was such a shock that trading of the company's stock was temporarily halted on the rumors alone. But MannKind executives are maintaining the market overreacted to the decision, which they say wasn't nearly as bad as first feared. It was widely assumed the FDA decision would result in a minimum two-year delay in the drug's rollout... Read more |
Patents
| | The Irvine-Based BIOLASE Issued New Patent for Use of Laser Technologies for Eye Surgery | | The patent is number 7,867,223 and is titled "Methods for Treating Hyperopia and Presbyopia via Laser Tunneling." It covers the use of Erbium-based pulsed lasers to increase or facilitate an increase in accommodation, mitigating the effects of presbyopia, enabling the eye to refocus at near distance without losing its ability to focus at a distance... Read more |
New Products
| | Burton Medical Offers Light Caress Fixtures for Multi-Function Lighting For Acute Care Patient Rooms |  The Chatsworth-based Burton Medical, Inc., the leader in examination and minor surgery lighting equipment, introduces Light Caress AC, PC and XC fixtures that incorporate a full complement of lighting functions in one unit for acute care patient rooms for both patients and healthcare professionals... Read more |
Latest Jobs
| IntriMed Technologies (Ventura) ChromoLogic (Pasadena) - ENGINEERING MANAGER - DEVELOPMENT
- RESEARCH SCIENTIST - BIOMEDICAL/BIOINFORMATICS
- RESEARCH SCIENTIST - SOFTWARE
- RESEARCH SCIENTIST - BIOMEDICAL
- RESEARCH SCIENTIST - OPTICS
- RESEARCH SCIENTIST - MECHANICAL
West Coast Clinical Trials (Cypress)
|
| About SoCalBio |  SoCalBio membership links you to partners, contract manufacturers, regulatory and legal experts, and policy makers. The organization's programs help emerging biotech and medical device companies grow. Membership is affordable -- as low as $500 -- and offers access to networking opportunities, advocacy, discounts through our group purchasing program group purchasing program and other benefits you simply can't find elsewhere ... Join SoCalBio |
| |
|
